Table 6.
Controls | Diabetic HD | Nondiabetic HD | All HD | |
---|---|---|---|---|
Monocytes (/μl) | 480 [210] | 600 [430] | 535 [350] | 565 [370] |
Mo1 (/μl) | 374 [187] | 441 [249] | 354 [290] | 428 [260] |
Mo2 (/μl) | 24 [18] | 40 [59] | 41 [21]* | 41 [27] |
Mo3 (/μl) | 76 [43] | 121 [104] | 126 [69]* | 126 [90] |
CD143+/Mo1 (MFI) | 1.1 [1.8] | 1.5 [6.0] | 2.1 [8.6] | 1.8 [7.5] |
CD143+/Mo2 (MFI) | 2.2 [1.8] | 2.9 [7.1] | 4.3 [10.4] | 3.7 [8.0] |
CD143+/Mo3 (MFI) | 2.7 [1.4] | 4.2 [5.0] | 5.0 [5.6]** | 4.3 [5.0] |
* = p < 0.05 vs. controls; ** = p < 0.01 vs. controls by Kruskal-Wallis and Dunn’s test. Statistical tests were done for the three groups controls, diabetic and non-diabetic patients. The column “all HD” remained untested. MFI: Mean fluorescence intensity